MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
The Motley Fool
September 5, 2006
Brian Gorman
Bayer Rising? Bayer still has some hoops to jump through before it's in tip-top shape, but the company has some tantalizing opportunities. Investors, it's not too early to put the German conglomerate on the watch list. mark for My Articles similar articles
The Motley Fool
March 27, 2006
Rich Smith
Bayer Prescribes Itself a Buyout Bayer's bid for Schering trumped an earlier $17.5 billion offer from yet another German powerhouse, Merck KGaA. Why would Bayer pay so much for Schering? Investors, take note. mark for My Articles similar articles
The Motley Fool
August 29, 2006
S.J. Caplan
Bayer's Crop Headache The company's second-quarter earnings are up while crops drag. Investors, take note. mark for My Articles similar articles
IndustryWeek
September 1, 2002
John S. McClenahen
Bayer's Formula: Two Sites Both Research Triangle Park, N.C., and Kansas City, Mo., are home to newly created Bayer CropScience's North American Operations. mark for My Articles similar articles
Chemistry World
September 18, 2012
Andrew Turley
Bayer $145 million animal health deal Bayer has signed a $145 million deal to buy the US part of the animal health business at Israeli generics giant Teva. mark for My Articles similar articles
The Motley Fool
July 20, 2004
Brian Gorman
Bayer Reshuffles Business Bayer, one of Germany's most venerable industrial names, is revamping its house. Seemingly in one fell swoop, the company is spinning off its Lanxess chemicals and polymers unit and buying Roche's over-the-counter-drugs business. mark for My Articles similar articles
Chemistry World
July 5, 2012
Bayer buys crop protection firm for $425m German chemical and healthcare giant Bayer has struck a deal to buy US firm AgraQuest, which makes pest control products based on 'natural' or specially bred microorganisms. mark for My Articles similar articles
BusinessWeek
April 8, 2010
Arlene Weintraub
Diabetes Is No Fun, but It Can Be a Game Bayer hopes that partnering with Nintendo will make it the leader in glucose testing. mark for My Articles similar articles
Chemistry World
September 23, 2014
Andy Extance
Bayer to sever polymer arm The German chemical giant has announced plans to spin off its MaterialScience business as a new company within 12 -- 18 months. mark for My Articles similar articles
The Motley Fool
November 30, 2006
Brian Lawler
Not Bad, Bayer The company's buyout of fellow German firm Schering AG looks like a boon to its bottom line. Investors, take note. mark for My Articles similar articles
Chemistry World
August 24, 2009
Sarah Houlton
Indian court dismisses Bayer's patent law case Bayer has failed in its attempt to stop Indian regulators giving marketing authorization to a generic version of its kidney cancer drug Nexavar (sorafenib), despite its 20 year patent having only been granted last year. mark for My Articles similar articles
Chemistry World
September 2, 2009
Helen Carmichael
Bayer bows to safety concerns One year after an explosion that led to two fatalities, Bayer CropScience is to eliminate 80 per cent of its methyl isocyanate stockpile at its Institute, West Virginia site. mark for My Articles similar articles
The Motley Fool
November 29, 2004
Brian Gorman
Glass Half Full for Bayer Bayer is battling drug recall demons, but the company's positives seem to outweigh its negatives. The German drug and chemical giant posted a net profit of $42 million, reversing a massive loss recorded in the same period last year. mark for My Articles similar articles
The Motley Fool
March 3, 2005
Brian Gorman
Bayer Heals Itself The latest earnings report suggests things are looking up -- and drug development may soon yield more good news for investors. mark for My Articles similar articles